Teligent Inc (TLGT, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Teligent Inc is a specialty generic pharmaceutical company. It markets and sells generic topical and branded generic injectable pharmaceutical products in the United States and Canada. Teligent Inc has a market cap of $14.380 million; its shares were traded at around $0.27 with and P/S ratio of 0.22. GuruFocus has detected 2 severe warning signs with Teligent Inc. .
For the last quarter Teligent Inc reported a revenue of $16.0 million, compared with the revenue of $16.78 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $65.9 million, an increase of 0% from last year. For the complete 30-year financial data, please go here.. For the last five years Teligent Inc had an average revenue growth rate of 13.7% a year.
The reported loss per diluted share was 47 cents for the year, compared with the loss per share of $0.07 in the previous year. The Teligent Inc had an operating margin of -12.17%, compared with the operating margin of -22.92% a year before. The 10-year historical median operating margin of Teligent Inc is -21.26%. The profitability rank of the company is 4 (out of 10).
At the current stock price of $0.27, Teligent Inc is traded at 96.2% discount to its historical median P/S valuation band of $7.06. The P/S ratio of the stock is 0.22, while the historical median P/S ratio is 5.49. The stock lost 74.08% during the past 12 months.
For the complete 20-year historical financial data of TLGT, click here.
